5-methylurapidil has been researched along with terazosin in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (66.67) | 18.2507 |
2000's | 2 (22.22) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bondinell, WE; Hieble, JP; Ruffolo, RR | 1 |
Ballard, S; Blagg, J; Fox, D; Kenny, B | 1 |
Arredondo, NF; Bantle, GW; Blue, DR; Clarke, DE; DeSousa, A; Elworthy, TR; Ford, AP; Gross, LM; Kava, MS; Lesnick, JD; Morgans, DJ; Ozer, RS; Palmer, WS; Pfister, JR; Repke, DB; Romero, M; Sandoval, L; Sjogren, EB; Talamás, FX; Vazquez, A; Vimont, RL; Williams, TJ; Wu, H; Zhu, QM | 1 |
Pedretti, A; Testa, B; Villa, L; Vistoli, G | 1 |
Carter, AJ; Greengrass, PM; Kenny, BA; Naylor, AM; Read, AM; Wyllie, MG | 1 |
Drescher, P; Knes, JM; Madsen, PO; Rauch, D | 1 |
Chiba, T; Fukutomi, J; Hattori, K; Maruyama, K; Nagatomo, T; Takeda, M; Yamaguchi, M | 1 |
Alcaide, C; González-Juanatey, JR; Iglesias, MJ; Lago, F; Piñeiro, R | 1 |
Du, H; He, L; Ren, J; Wang, S | 1 |
2 review(s) available for 5-methylurapidil and terazosin
Article | Year |
---|---|
Alpha- and beta-adrenoceptors: from the gene to the clinic. 1. Molecular biology and adrenoceptor subclassification.
Topics: Animals; Humans; Molecular Biology; Molecular Structure; Radioligand Assay; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta | 1995 |
Pharmacological options in the treatment of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship | 1997 |
7 other study(ies) available for 5-methylurapidil and terazosin
Article | Year |
---|---|
N-arylpiperazinyl-N'-propylamino derivatives of heteroaryl amides as functional uroselective alpha 1-adrenoceptor antagonists.
Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Amides; Animals; Binding, Competitive; Humans; Male; Middle Aged; Models, Chemical; Muscle, Smooth; Piperazines; Prazosin; Propylamines; Prostatic Hyperplasia; Rabbits; Rats; Structure-Activity Relationship; Urinary Bladder | 1997 |
Range and sensitivity as descriptors of molecular property spaces in dynamic QSAR analyses.
Topics: Chemical Phenomena; Chemistry, Physical; Ligands; Models, Molecular; Molecular Conformation; Monte Carlo Method; Quantitative Structure-Activity Relationship; Receptors, Adrenergic, alpha-1; Solvents | 2005 |
Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog.
Topics: Adrenergic alpha-Antagonists; Affinity Labels; Anesthesia, Endotracheal; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Doxazosin; Male; Models, Biological; Phenylephrine; Piperazines; Prazosin; Pressure; Prostate; Quinazolines; Sulfonamides; Tamsulosin | 1994 |
Contrast medium induced renal vasoconstriction, role of alpha receptors.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Contrast Media; Dose-Response Relationship, Drug; Drug Interactions; Phenylephrine; Piperazines; Prazosin; Rabbits; Radiography; Receptors, Adrenergic, alpha-1; Renal Artery; Sulfonamides; Tamsulosin; Vasoconstriction; Vasoconstrictor Agents | 1995 |
Two district alpha(1)-adrenoceptor subtypes in the human prostate: assessment by radioligand binding assay using 3H-prazosin.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Binding, Competitive; Dioxanes; Humans; In Vitro Techniques; Kinetics; Male; Nifedipine; Phentolamine; Piperazines; Prazosin; Prostate; Protein Binding; Radioligand Assay; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tritium | 1996 |
Doxazosin induces apoptosis in cardiomyocytes cultured in vitro by a mechanism that is independent of alpha1-adrenergic blockade.
Topics: 3T3 Cells; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Antihypertensive Agents; Apoptosis; Calcineurin Inhibitors; Cell Survival; Cells, Cultured; Doxazosin; Heart; Humans; Mice; Myocardium; Piperazines; Prazosin; Rats; Rats, Sprague-Dawley | 2003 |
Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions.
Topics: Adrenergic alpha-1 Receptor Antagonists; Binding, Competitive; Cell Line; Cell Membrane; Chromatography; Doxazosin; Humans; Methods; Phentolamine; Piperazines; Prazosin; Protein Binding; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin | 2011 |